Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Hepatology

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.20819PMID 16149085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Hepatitis B and Viral Genotype: The Clinical Significance of Determining HBV Genotypes

  2005cited by this paper
• The Los Alamos hepatitis C sequence database

  2005cited by this paper
• Chronic Hepatitis C and Genotyping: The Clinical Significance of Determining HCV Genotypes

  2005cited by this paper
• Full-length genomic sequence of a hepatitis C virus genotype 2c isolate (BEBE1) and the 2c-specific PCR primers

  2005cited by this paper
• Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation.

  2004cited by this paper
• HCVDB: hepatitis C virus sequences database.

  2004cited by this paper
• Full-genome Nucleotide Sequence of a Hepatitis C Virus Variant (Isolate Name VAT96) Representing a New Subtype within the Genotype 2 (Arbitrarily 2k)

  2004cited by this paper
• Evidence of intratypic recombination in natural populations of hepatitis C virus.

  2004cited by this paper
• Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon.

  2003cited by this paper
• Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers.

  2003cited by this paper
• The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach.

  2003cited by this paper
• Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum Samples

  2003cited by this paper
• Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.

  2003cited by this paper
• Frequent Recovery and Broad Genotype 2 Diversity Characterize Hepatitis C Virus Infection in Ghana, West Africa

  2003cited by this paper
• Direct comparison of hepatitis C virus genotypes tested by INNO-LiPA HCV II and TRUGENE HCV genotyping methods.

  2003cited by this paper
• 548 Use of nucleotide sequence analysis of the NS5B region for routine genotyping of hepatitis C virus: Identification of numerous variants not classifiable into the known HCV genotypes

  2003cited by this paper
• A Natural Intergenotypic Recombinant of Hepatitis C Virus Identified in St. Petersburg

  2002cited by this paper
• A genetic analysis of hepatitis C virus transmission between injection drug users.

  2002cited by this paper
• Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns.

  2001cited by this paper
• The Epidemic Behavior of the Hepatitis C Virus

  2001cited by this paper
• Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient *

  2001cited by this paper
• MEGA2: molecular evolutionary genetics analysis software

  2001cited by this paper
• Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment

  2001cited by this paper
• Down-regulation of translation driven by hepatitis C virus internal ribosomal entry site by the 3′ untranslated region of RNA

  2001cited by this paper
• The origin and evolution of hepatitis viruses in humans.

  2001cited by this paper
• The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

  2000cited by this paper
• Genetic epidemiology of hepatitis C virus throughout egypt.

  2000cited by this paper
• A novel hepatitis C virus (HCV) subtype from Somalia and its classification into HCV clade 3.

  2000cited by this paper
• Genotyping of Hepatitis C Virus Isolates using CLIP Sequencing

  2000cited by this paper
• HIV-1 Nomenclature Proposal

  2000cited by this paper
• Determination of HCV Genotypes by RFLP.

  1999cited by this paper
• Molecular Evidence of Mother-to-Infant Transmission of Hepatitis G Virus among Women without Known Risk Factors for Parenteral Infections

  1999cited by this paper
• HCV Genotyping by the Line Probe Assay INNO-LiPA HCV II.

  1999cited by this paper
• Evidence for high genetic diversity and long‐term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa

  1998cited by this paper
• Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization

  1998cited by this paper
• Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: genetic analysis of the virus and generation of a standardized challenge pool.

  1998cited by this paper
• Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana.

  1998cited by this paper
• The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups.

  1998cited by this paper
• Complete coding sequence of hepatitis C virus genotype 6a.

  1997cited by this paper
• The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa.

  1997cited by this paper
• Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East.

  1997cited by this paper
• Identification of a highly conserved sequence element at the 3' terminus of hepatitis C virus genome RNA

  1996cited by this paper
• Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6

  1996cited by this paper
• Identification of numerous hepatitis C virus genotypes in Montreal, Canada

  1996cited by this paper
• Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay

  1996cited by this paper
• Second-generation line probe assay for hepatitis C virus genotyping

  1996cited by this paper
• Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity.

  1996cited by this paper
• Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups.

  1996cited by this paper
• Hepatitis C virus (HCV) genotype analysis in apparently healthy anti‐ HCV‐positive Parisian blood donors

  1996cited by this paper
• Genotype determination of hepatitis C virus from Northern India: Identification of a new subtype

  1996cited by this paper
• Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry).

  1996cited by this paper
• Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countries.

  1995cited by this paper
• Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.

  1995cited by this paper
• Variation of the hepatitis C virus 5' non-coding region: implications for secondary structure, virus detection and typing. The International HCV Collaborative Study Group.

  1995cited by this paper
• Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups.

  1995cited by this paper
• Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes.

  1995cited by this paper
• Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group.

  1995cited by this paper
• HCV infection in a rural population of the Central African republic (CAR): Evidence for three additional subtypes of genotype 4

  1995cited by this paper
• Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States.

  1995cited by this paper
• Hepatitis C virus genotyping by means of 5'-UR/core line probe assays and molecular analysis of untypeable samples.

  1995cited by this paper
• A proposed system for the nomenclature of hepatitis C viral genotypes

  1994cited by this paper
• Nucleotide sequence of hepatitis C virus (type 3b) isolated from a Japanese patient with chronic hepatitis C.

  1994cited by this paper
• Heterogeneity of hepatitis C virus genotypes in France.

  1994cited by this paper
• Significance of specific antibody assay for genotyping of hepatitis C virus

  1994cited by this paper
• Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups.

  1994cited by this paper
• Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group.

  1994cited by this paper
• Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand

  1994cited by this paper
• Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon).

  1994cited by this paper
• Full-length sequence of the genome of hepatitis C virus type 3a: comparative study with different genotypes.

  1994cited by this paper
• The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease.

  1994cited by this paper
• Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a.

  1994cited by this paper
• Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions.

  1994cited by this paper
• Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes.

  1994cited by this paper
• Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

  1994cited by this paper
• A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody.

  1993cited by this paper
• At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

  1993cited by this paper
• Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3

  1993cited by this paper
• Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

  1993cited by this paper
• Detection of three types of hepatitis C virus in blood donors: investigation of type‐specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities

  1993cited by this paper
• Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection.

  1993cited by this paper
• Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay.

  1993cited by this paper
• Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants.

  1992cited by this paper
• Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.

  1992cited by this paper
• Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes.

  1992cited by this paper
• At least five related, but distinct, hepatitis C viral genotypes exist.

  1992cited by this paper
• Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus.

  1992cited by this paper
• A new type of hepatitis C virus in patients in Thailand.

  1992cited by this paper
• Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins.

  1991cited by this paper
• A second group of hepatitis C viruses

  1991cited by this paper
• Structure and organization of the hepatitis C virus genome isolated from human carriers

  1991cited by this paper
• Genetic organization and diversity of the hepatitis C virus.

  1991cited by this paper
• Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates.

  1991cited by this paper
• Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis.

  1990cited by this paper
• There are two major types of hepatitis C virus in Japan.

  1990cited by this paper

• Prevalence of Active Hepatitis C Virus Infection in General Population of District Hangu, (KPK) Pakistan

  2026cites this paper
• Reducing haystacks to needles – ViralClust: A Nextflow pipeline to cluster viral sequences

  2026cites this paper
• Identification of novel hepaciviruses and Sylvilagus-associated viruses via metatranscriptomics in North American lagomorphs.

  2025cites this paper
• Sero Positivity of Hepatitis C among Patients with β-Thalassemia Major in Karbala Center

  2025cites this paper
• Bothropstoxins I and II as potent phospholipase A2 molecules from Bothrops jararacussu to impair Hepatitis C virus infection.

  2025cites this paper
• Heavy metal exposure and hepatitis C virus infection: A cross-sectional study.

  2025cites this paper
• A comprehensive diagnostic framework for hepatitis C using structured data and predictive analytics

  2025cites this paper
• A panel of hepatitis C virus glycoproteins for the characterization of antibody responses using antibodies with diverse recognition and neutralization patterns

  2024cites this paper
• Contemporary Insights into Hepatitis C Virus: A Comprehensive Review

  2024cites this paper
• Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease

  2024cites this paper
• Update on Hepatitis C Virus (HCV) Vaccine Candidates in Clinical Trials: A Systematic Literature Review

  2024cites this paper
• Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection

  2024cites this paper
• A critique of the use of species and below-species taxonomic terms for viruses—time for change?

  2024cites this paper
• The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy.

  2024cites this paper
• Prediction of viral families and hosts of single-stranded RNA viruses based on K-Mer coding from phylogenetic gene sequences

  2024cites this paper
• Hepatitis C virus subtype distribution and resistance-associated substitutions in high-risk population groups in Guangdong Province, China.

  2024cites this paper
• Detection of Hepatitis C Virus Infection from Patient Sera in Cell Culture Using Semi-Automated Image Analysis

  2024cites this paper
• First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus

  2024cites this paper
• Epidemiology of Hepatitis C Virus in HIV Patients from West Mexico: Implications for Controlling and Preventing Viral Hepatitis

  2024cites this paper
• Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis

  2024cites this paper
• Comparative Evaluation of Open-Source Bioinformatics Pipelines for Full-Length Viral Genome Assembly

  2024cites this paper
• Update on Hepatitis C Vaccine: Results and Challenges

  2024cites this paper
• Hepatitis C Virus—Core Antigen: Implications in Diagnostic, Treatment Monitoring and Clinical Outcomes

  2024cites this paper
• Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures

  2023cites this paper
• HCV Genotype Distribution and Clinical Characteristics of HCV Mono-Infected and HCV/HIV Co-Infected Patients in Liangshan Prefecture, Sichuan Province, China

  2023cites this paper
• NeTaGFT: A similarity network‐based method for trait analysis

  2023cites this paper
• Modulation of the replication of positive-sense RNA viruses by the natural plant metabolite xanthohumol and its derivatives

  2023cites this paper
• Hepatitis C virus prevalence among men who have sex with men: a cross-sectional study in 12 Brazilian cities

  2023cites this paper
• Optimizing HCV Disease Prediction in Egypt: The hyOPTGB Framework

  2023cites this paper
• Genetic history of hepatitis C virus genotype 6 in Taiwan.

  2023cites this paper
• Genomic analysis of circulating HIV and hepatitis C virus infections and coinfections in Cameroon: 2005–2006 and 2015–2016

  2023cites this paper
• Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies

  2023cites this paper
• Malignancy and viral infections in Sub-Saharan Africa: A review

  2023cites this paper
• Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes.

  2023cites this paper
• Metabolic, renal, and hematological changes in chronic hepatitis C patients achieving rapid virologic response after 12 weeks of direct-acting antiviral treatment: A prospective cohort study

  2023cites this paper
• Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents

  2023cites this paper
• Growth history of hepatitis C virus among HIV/HCV co-infected patients in Guizhou Province

  2023cites this paper
• Virological characterization of treatment failures and retreatment outcomes in patients infected with “unusual” HCV genotype 1 subtypes

  2023cites this paper
• A novel candidate hepatitis C virus genotype 4 subtype identified by next generation sequencing full-genome characterization in a patient from Saudi Arabia

  2023cites this paper
• Genotype Distribution and Characteristics of Chronic Hepatitis C Infection in Estonia, Latvia, Lithuania, and Ukraine: The RESPOND-C Study

  2023cites this paper
• Computational identification of a multi-peptide vaccine candidate in E2 glycoprotein against diverse Hepatitis C virus genotypes

  2023cites this paper
• Elimination of hepatitis C in the Middle East: a narrative review of the efficacy of direct-acting antiviral therapies

  2023cites this paper
• Quantitative and Qualitative Evaluation of Hepatitis C Virus Core Antigen (HCVcAg) as an Alternative Diagnostic Marker in Chronic HCV Infection

  2023cites this paper
• Hepatitis C Virus Genotyping from anti-HCV Negative Sera in Blood Donors

  2023cites this paper
• Genotypes of Hepatitis C Virus and Efficacy of Direct-Acting Antiviral Drugs among Chronic Hepatitis C Patients in a Tertiary Care Hospital

  2023cites this paper
• The Role of Cytosolic Lipid Droplets in Hepatitis C Virus Replication, Assembly, and Release

  2023cites this paper
• The Human Liver-Expressed Lectin CD302 Restricts Hepatitis C Virus Infection

  2022cites this paper
• HCV 6a was expanding and became the predominant subtype among blood donors between 2004 and 2019 in Guangdong, China

  2022cites this paper
• Extrahepatic manifestations of chronic viral hepatitis C

  2022cites this paper
• A unified classification system for HIV-1 5’ long terminal repeats

  2022cites this paper
• A proposed disease classification system for duck viral hepatitis

  2022cites this paper
• Hepatitis C virus data analysis and prediction using machine learning

  2022cites this paper
• Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective.

  2022cites this paper
• Seroprevalence of transfusion transmissible hepatitis viruses in Kwara state Nigeria.

  2022cites this paper
• A Hepatitis C virus genotype 1b post-transplant isolate with high replication efficiency in cell culture and its adaptation to infectious virus production in vitro and in vivo

  2022cites this paper
• PhyGraFT: a network-based method for phylogenetic trait analysis

  2022cites this paper
• Genetic diversity of Hepatitis C Virus and resistance associated substitutions to Direct-Acting Antiviral treatment in Colombia.

  2022cites this paper
• Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs

  2022cites this paper
• Tertiary Structure Prediction and Analysis of the Non-structural Protein 5B of Hepatitis C Virus Genotype 4a

  2022cites this paper
• Epidemiology, risk factors, and pathogenesis associated with a superbug: A comprehensive literature review on hepatitis C virus infection

  2022cites this paper
• Next-Generation Sequencing for Confronting Virus Pandemics

  2022cites this paper
• Association between Cluster of Differentiation 24 (CD24) Polymorphism, Talin-1 gene expression and Hepatocellular Carcinoma prevalence in Egyptian population

  2021cites this paper
• Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis

  2021cites this paper
• Evolution of the SARS‐CoV‐2 proteome in three dimensions (3D) during the first 6 months of the COVID‐19 pandemic

  2021cites this paper
• Haplotype Network Analysis and Phylogenetic Tree Construction of Hepatitis C Virus (HCV) Isolated from Tuban, Indonesia

  2021cites this paper
• Assessing hepatitis C virus distribution among vulnerable populations in London using whole genome sequencing: results from the TB-REACH study

  2021cites this paper
• Detection of Hepatitis C Virus Genotype 1a among Patients from Al-Nasiriya City and Determining its Transmission Risk Factors

  2021cites this paper
• Prevalence of Hepatitis C virus Genotype among Hemodialysis Patients Two Centers Study in Baghdad, Iraq

  2021cites this paper
• The predominance of Hepatitis C Virus Genotypes and Its Association with the Viral Load in Bangladeshi Population

  2021cites this paper
• Inhibition of viral RNA-dependent RNA polymerases with clinically relevant nucleotide analogs

  2021cites this paper
• A Review of Hepatitis C Virus: Prevalence, Genotype, Risk Factors in Pakistan Last Quarter of Century

  2021cites this paper
• Genotype distribution and risk factors in patients with chronic hepatitis C infection

  2021cites this paper
• Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution

  2021cites this paper
• Classification, Genetic Diversity and Global Distribution of Hepatitis C Virus (HCV) Genotypes and Subtypes

  2021cites this paper
• Immunoassay and Genotyping of Hepatitis C virus in Ramadi City

  2021cites this paper
• Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis

  2021cites this paper
• Hepatitis C Virus with Focus on Genotype or Subtype Spread in Punjab Province of Pakistan

  2021cites this paper
• Hepatitis C Virus Origin

  2021cites this paper
• HCVのウイルス学的特徴とHCV genotypeについて：①基礎

  2021cites this paper
• Hepatitis C virus genotype 4: A poorly characterized endemic genotype

  2021cites this paper
• Distribution of naturally -occurring NS5B resistance-associated substitutions in Egyptian patients with chronic Hepatitis C

  2021cites this paper
• The genotype analysis of the hepatitis C virus in Heilongjiang Province, China

  2021influential citation
• Identification of two novel hepatitis C virus subtype 2 from Tunisia (2v and 2w)

  2021cites this paper
• Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies

  2021cites this paper
• Geographic Variation of Indigenous Hepatitis C Virus Subtypes 6g and 6w in an Endemic Area of Southern Taiwan

  2021cites this paper
• Validated High-performance Liquid Chromatography Method for the Determination of JW5624, A New Class Of Hepatitis C Virus Inhibitor, in Rat Plasma and its Application in the Pharmacokinetic Study of JW5624

  2021cites this paper
• RETRACTED ARTICLE: Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors

  2021cites this paper
• Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who Was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir

  2021cites this paper
• Using host genetics to infer the global spread and evolutionary history of HCV subtype 3a

  2021cites this paper
• Host-Targeting Antivirals for Treatment of Hepatitis C

  2021cites this paper
• Focus on hepatitis C virus genotype distribution in Tunisia prior to elimination: a 16-year retrospective study

  2021cites this paper
• The Effectiveness of Sovodak in the Treatment of Patients with Chronic Hepatitis C

  2021cites this paper
• Evaluation of the Inflammatory Cytokines and IL-10 Network in Individuals Co-infected With Human T-Cell Lymphotropic Virus and Hepatitis C Virus (HTLV/HCV)

  2021cites this paper
• Identification of a novel replication-competent hepatitis C virus variant that confers the sofosbuvir resistance.

  2021cites this paper
• The role of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in the assessment of fibrosis in children with chronic hepatitis C

  2021cites this paper
• Hepatitis С in Russia and the Northwest federal region of Russia: results of the first stage the global programme of infection elimination

  2021cites this paper
• Efficacy of sofosbuvir in the treatment-naïve patients infected with 3a genotype of Hepatitis C.

  2021cites this paper
• Current HCC Clinical and Research in Egypt

  2021cites this paper
• A Concise Review on the Frequency, Major Risk Factors and Surveillance of Hepatocellular Carcinoma (HCC) in β-Thalassemias: Past, Present and Future Perspectives and the ICET-A Experience

  2020cites this paper
• Domain I of hepatitis C virus NS5A associates with ACBD3 in a genotype-dependent manner.

  2020cites this paper